Ortho Clinical Diagnostics Holdings Plc (OCDX) Inventory Turnover Ratio, from first quarter 2022 to first quarter 2021, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Ortho Clinical Diagnostics Holdings Plc  (NASDAQ: OCDX)
 

Ortho Clinical Diagnostics Holdings Plc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2022, Ortho Clinical Diagnostics Holdings Plc's inventory turnover ratio sequentially decreased to 3.26 in the first quarter 2022, unsurprisingly, as the Ortho Clinical Diagnostics Holdings Plc markets continue to deteriorate, and OCDX's faces growing challenges to bring down its inventories. Ortho Clinical Diagnostics Holdings Plc's average inventory processing period in the Apr 03 2022 quarter, has increased to 112 days, from 110 days, in the Jan 02 2022 quarter.

Within Healthcare sector 151 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 897 in the fourth quarter 2022, to 909.

OCDX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Ortho Clinical Diagnostics Holdings Plc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OCDX Inventory Turnover Ratio (Apr 03 2022)
I. Quarter		 (Jan 02 2022)
IV. Quarter		 (Oct 03 2021)
III. Quarter		 (Jul 04 2021)
II. Quarter		 (Apr 04 2021)
I. Quarter
Y / Y Inventory Growth 8.79 % 9.58 % - - -
Y / Y Cost of Sales Growth 0.52 % 0.04 % 7.82 % 22.28 % 16.42 %
Inventory Turnover Ratio (TTM) 3.26 3.33 3.4 4.52 6.62
OCDX's Total Ranking # 909 # 897 # 0 # 0 # 892
Average inventory processing period 112 110 107 81 55
Seq. Inventory Growth 3.7 % -0.94 % 1.08 % 4.77 % 4.45 %
Seq. Cost of Sales Growth -3.33 % 2.26 % 1.73 % -0.04 % -3.8 %




Inventory Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 7
Healthcare Sector # 152
Overall Market # 909

Inventory Turnover Ratio Statistics
High Average Low
3.33 3.3 3.26
(Jan 02 2022)   (Apr 03 2022)



OCDX Company Profile >> Back to OCDX Efficiency Comparisons >> Compare OCDX Inventory Turnover Ratio to its Competitors

Financial Statements
Ortho Clinical Diagnostics Holdings Plc's Inventories $ 317 Millions Visit OCDX's Balance sheet
Ortho Clinical Diagnostics Holdings Plc's Cost of Revenues TTM $ 1,008 Millions Visit OCDX's Income Statement
What are OCDX's Sales? Visit OCDX's Sales by Segment

Other Inventory Turnover Ratios
Ortho Clinical Diagnostics Holdings Plc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
OCDX's Inventory Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for OCDX's Competitors
Inventory Turnover Ratio for OCDX's Suppliers
Inventory Turnover Ratio for OCDX's Customers

You may also want to know
OCDX's Sales Growth Rates OCDX's Pe Price to earnings ratio OCDX's Receivables Turnover Ratio OCDX's Stock Quote
OCDX's Net Income Growth Rates OCDX's Ps Price to Sales ratio OCDX's Sales per Employee OCDX's Asset Turnover Ratio
OCDX's Net Margin OCDX's Pb Price to Book ratio OCDX's Financial Strength Ratios OCDX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Apr 03 2022, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Apr 03 2022 Inventories at quarter ending Apr 03 2022
Biotricity Inc   8.72 $ 3.080  Millions$ 0  Millions
Castle Biosciences Inc   8.45 $ 18.738  Millions$ 2  Millions
Vyant Bio Inc   8.43 $ 3.919  Millions$ 0  Millions
Sunlink Health Systems Inc   8.31 $ 15.830  Millions$ 2  Millions
Cryoport inc   7.99 $ 127.258  Millions$ 16  Millions
Lantheus Holdings Inc   7.87 $ 265.844  Millions$ 34  Millions
Hims and Hers Health Inc   7.59 $ 81.875  Millions$ 11  Millions
National Vision Holdings Inc   7.38 $ 916.126  Millions$ 124  Millions
Kewaunee Scientific Corporation  7.26 $ 144.652  Millions$ 20  Millions
Revvity Inc  7.21 $ 3,935.583  Millions$ 546  Millions
Adm Tronics Unlimited Inc   7.16 $ 1.958  Millions$ 0  Millions
Lftd Partners Inc   7.04 $ 22.913  Millions$ 3  Millions
Bionexus Gene Lab Corp   6.91 $ 10.998  Millions$ 2  Millions
Collegium Pharmaceutical Inc   6.84 $ 230.071  Millions$ 34  Millions
Guardion Health Sciences Inc   6.79 $ 4.990  Millions$ 1  Millions
Veracyte Inc   6.54 $ 65.551  Millions$ 10  Millions
Incyte Corporation  6.49 $ 164.385  Millions$ 25  Millions
Societal Cdmo Inc   6.42 $ 57.314  Millions$ 9  Millions
Patterson Companies Inc   6.40 $ 5,210.318  Millions$ 814  Millions
Kaya Holdings Inc   6.40 $ 0.267  Millions$ 0  Millions
Fonar Corporation  6.38 $ 12.705  Millions$ 2  Millions
Carlisle Companies Incorporated  6.37 $ 3,733.700  Millions$ 586  Millions
Nexgel Inc   6.25 $ 1.652  Millions$ 0  Millions
Puma Biotechnology Inc   6.16 $ 44.988  Millions$ 7  Millions
Aquestive Therapeutics Inc   6.11 $ 21.946  Millions$ 4  Millions
Prophase Labs Inc   6.02 $ 49.564  Millions$ 8  Millions
Retractable Technologies Inc  5.82 $ 99.951  Millions$ 17  Millions
Ufp Technologies Inc   5.80 $ 173.324  Millions$ 30  Millions
Integer Holdings Corporation  5.80 $ 907.565  Millions$ 157  Millions
Rvl Pharmaceuticals Plc  5.78 $ 5.083  Millions$ 1  Millions

Date modified: 2026-08-29T17:43:13+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.